In our study, the protein expression levels of CDCP1 were significantly elevated in patients in the cognitively impaired groups (AD and MCI patients), suggesting that dynamic fluctuations in CDCP1 levels may mirror disease progression in AD. The gene discussed is CDCP1; the disease is Alzheimer disease.